publications_code_1400x400px

The LSE Health Working Paper Series in Health Policy and Economics

The Working Paper Series enables staff and student researchers based at or affiliated with LSE Health to make recent work and work in progress available to a wider audience.
It reflects the range and diversity of theoretical and empirical work relating to health policy and economics carried out at LSE Health.

Working Papers 1 - 10

WP1
Inequality in health care use among older people in the United Kingdom: an analysis of panel data by Sara Allin, Cristina Masseria and Elias Mossialos.        

WP2
A conceptual framework for community-based health insurance in low-income countries: social capital and economic development by Philipa Mladovsky and Elias Mossialos.            

WP3
Equity in the use of health services in Canada and its provinces by Sara Allin.           

WP4
Regulating private health insurance in the European Union: the implications of single market legislation and competition policy
by Sarah Thomson and Elias Mossialos.            

WP5
Inferring the Value of Medical Research to the UK
by Alistair McGuire and Maria Raikou.            

WP6
Medicines parallel trade in the European Union: a gravity specification by Joan Costa-Font and Panos Kanavos            

WP8
Gains in QALYs vs DALYs averted: the troubling implications of using residual life expectancy by Mara Airoldi           

WP9
Exploring the Pathways of Inequality in Health, Access and Financing in Decentralised Spain by Joan Costa-Fonta and Joan Gilb            

WP10
Conflict in the Doctor-Patient relation and Non-Adherence: A game theory approach
by Charitini Stavropoulou and Dionysius Glycopantis           

Working Papers 11 - 20

WP11
Reflections on the Development of Health Inequalities Policy in the United Kingdom
by Adam Oliver            

WP12
Decomposing cross-country differences in levels of obesity and overweight: does the social environment matter
? by Joan Costa-Font, Daniele Fabbri and Joan Gil            

WP13
Parametric estimation of medical care costs under conditions of censoring by Maria Raikou and Alistair McGuire            

WP14
An explorative study of "preferred" health care decision rules by Adam Oliver            

WP15
Body Image, Peer Effects and Food Disorders: Evidence from a Sample of European Women by Joan Costa-Font and Mireia Jofre-Bonet            

WP16
Does Hospital Competition Save Lives? Evidence From The Recent English NHS Choice Reforms by Zack Cooper, Stephen Gibbons, Simon Jones and Alistair McGuire            

WP17
Technology diffusion and health care productivity: angioplasty in the UK by Alistair McGuire, Maria Raikou, Frank Windmeijer and Victoria Serra-Sastre            

WP18
Medicine prices, availability and affordability in Southern Brazil: a study of public and private facilities by Andréa Dâmaso Bertoldi, Ana Paula Helfer, Aline L Camargo, Noêmia UL Tavares, Panos Kanavos            

WP19
Do International Launch Strategies of Pharmaceutical Corporations Respond to Changes in the Regulatory Environment by Nebibe Varol, Joan Costa-Font and Alistair McGuire            

WP20
Persistence despite Action? Measuring the Patterns of Health Inequality in England (1997-2007) by Joan Costa-Font, Cristina Hernádez-Quevedo and Alistair McGuire

Working Papers 21 - 30

WP21
Using a latent variable approach to measure the quality of English NHS hospitals by Irene Papanicolas and Alistair McGuire            

WP22
Using a Vector Autoregression Framework to measure the quality of English NHS hospitals by Irene Papanicolas and Alistair McGuire            

WP23
Demand and Pricing of Preventative Health Care by Sotiris Vandoros and Katherine Grace Carman            

WP24
Pathways towards chronic-care focused healthcare systems: evidence from Spain
by Manuel García-Goñi, Cristina Hernández-Quevedo, Roberto Nuño-Solinís, Francesco Paolucci            

WP25
Publication Selection in Health Policy Research: the Winner's Curse Hypothesis by Joan Costa-Font, Alistair McGuire and Tom Stanley            

WP26
Are Health Care 'Choice - and - Competition' Reforms really Efficiency Driven? by Joan Costa-Font and Valentina Zigante            

WP27
Does culture matter at all in explaining why people still use traditional medicines? by Azusa Sato and Joan Costa-i-Font            

WP28
The hedonic placebo effect of traditional medicines by Azusa Sato and Joan Costa-i-Font            

WP29
Do Income Gradients in Unhealthy Behaviours Explain Patterns of Health Inequalities? by Joan Costa-i-Font, Cristina Hernández-Quevedo and Dolores Jiménez-Rubio            

WP30
Intergenerational and Socioeconomic Gradients of Child Obesity by Joan Costa-Font and Joan Gil 

Working Papers 31 - 40

WP31
Globesity: Is Globalization a Pathway to Obesity? by Joan Costa-Font, Núria Mas and Patricia Navarro            

WP32
Inequalities in Self-Reported Health: A Meta-Regression Analysis by Joan Costa-Font and Cristina Hernández-Quevedo             

WP33
Multiple Criteria Decision Analysis for Value Based Assessment of New Medical Technologies: A Conceptual Framework by Panos Kanavos and Aris Angelis            

WP34
Using MCDA to assess value of new medical technologies by Aris Angelis and Panos Kanavos             

WP35
Analysis of prices paid by low-income countries - how price sensitive is government demand for medicines? by Divya Srivastava and Alistair McGuire            

WP36
Policy Dilemmas in Financing Long-term Care in Europe by Joan Costa-Font, Christophe Courbage and Peter Zweifel            

WP37
Long Term Care Coverage in Europe: A Case for 'Implicit Insurance Partnerships' by Joan Costa-Font and Valentina Zigante            

WP38
Assessing Long-Term Care Partnerships: An Old Concept to Redefine? by Savannah Bergquist, Joan Costa-Font and Katherine Swartz            

WP39
Treating epilepsy during pregnancy: a systematic literature review of the impact of drug treatment on mother and foetus by Federico Grimaccia and Panos Kanavos            

WP40
Treating rheumatoid arthritis during pregnancy: A systematic literature review of the impact of drug treatment on mother and foetus by Victoria Tzouma, Mari Grepstad and Panos Kanaovs

Working Papers 41 - 46

WP41
Treating schizophrenia during pregnancy: A systematic literature review on the impact of drug treatment on mother and foetus by Mari Grepstad, Victoria Tzouma, Federico Grimaccia and Panos Kanaovs            

WP42
An analysis of HTA decisions for orphan drugs in Canada and Australia
by Caroline Solon and Panos Kanavos            

WP43
Health Technology Assessment of Cancer Drugs in France and Germany - Commonalities and Differences in the Value Assessment of Medical Technologies by Anna Szerb and Panos Kanavos            

WP44
Comparisons of Health Technology Assessment Appraisal Outcomes and Methodologies in Oncology Indications across Four Countries by Nick Petersdorf and Panos Kanavos            

WP45 
A Comparative Analysis of the Regulatory Requirements of Orphan Medicinal Products in the United States and European Union by Emilie Taymor and Panos Kanavos            

WP46
The Blow of Domestic Violence on Children's Health Outcomes by Mireia Jofre-Bonet, Melcior Rossello-Roig and Victoria Serra-Sastre

 

For more information about the series, contact LSE Health

Please ensure all the details have been entered correctly in the Twitter control.

Contact us

Address

LSE Health, Cowdray House, London School of Economics and Political Science, Houghton Street, London WC2A 2AE

Follow us

Twiiter